STAVUDINE
Substance profile for UNII BO9LE4QFZF, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 18283Substance Identity#
- UNII
- BO9LE4QFZF
- Preferred term
- STAVUDINE
- Registry number
- 3056-17-5
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C10H12N2O4
Structure render from PubChem CID 18283Chemical And Database Identifiers#
- InChIKey
- XNKLLVCARDGLGL-JGVFFNPUSA-N
- SMILES
- CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O
- RxCUI
- 59763
- PubChem
- 18283
- NCIt
- C1428
- INN ID
- 6775
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | These highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules. Stavudine Capsules, USP Initial U.S. Approval: 1994 | 1 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | These highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules. Stavudine Capsules, USP Initial U.S. Approval: 1994 | 1 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | ZERIT ® (stavudine) Capsules ZERIT ® (stavudine) for Oral Solution | 3 | |
| stavudine | ACTIVE MOIETY | BO9LE4QFZF | ZERIT ® (stavudine) Capsules ZERIT ® (stavudine) for Oral Solution | 3 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | 081991e0-eee4-4fa3-ac3d-0c32cb03e7f3 | 1 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | 081991e0-eee4-4fa3-ac3d-0c32cb03e7f3 | 1 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | 752d2c13-5ca5-40b3-b066-55a9b6b1287a | 1 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | 752d2c13-5ca5-40b3-b066-55a9b6b1287a | 1 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE (STAVUDINE) CAPSULE [REMEDYREPACK INC. ] | 80 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE (STAVUDINE) CAPSULE [REMEDYREPACK INC. ] | 80 | |
| stavudine | ACTIVE INGREDIENT | BO9LE4QFZF | ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | 23 | |
| stavudine | ACTIVE MOIETY | BO9LE4QFZF | ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | 23 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE POWDER, FOR SOLUTION [AUROBINDO PHARMA LIMITED] | 9 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE POWDER, FOR SOLUTION [AUROBINDO PHARMA LIMITED] | 9 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE CAPSULE [AUROBINDO PHARMA LIMITED] | 8 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE CAPSULE [AUROBINDO PHARMA LIMITED] | 8 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 7 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 7 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE FOR SOLUTION [CIPLA LIMITED] | 4 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE FOR SOLUTION [CIPLA LIMITED] | 4 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE CAPSULE [CAMBER PHARMACEUTICALS, INC.] | 2 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE CAPSULE [CAMBER PHARMACEUTICALS, INC.] | 2 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE SOLUTION [BOCA PHARMACAL, LLC] | 2 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE SOLUTION [BOCA PHARMACAL, LLC] | 2 | |
| STAVUDINE | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE CAPSULE [KAISER FOUNDATION HOSPITALS] | 1 | |
| STAVUDINE | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE CAPSULE [KAISER FOUNDATION HOSPITALS] | 1 | |
| Stavudine | ACTIVE INGREDIENT | BO9LE4QFZF | STAVUDINE POWDER, FOR SOLUTION [EDENBRIDGE PHARMACEUTICALS, LLC] | 1 | |
| Stavudine | ACTIVE MOIETY | BO9LE4QFZF | STAVUDINE POWDER, FOR SOLUTION [EDENBRIDGE PHARMACEUTICALS, LLC] | 1 | |